The Zhitong Finance App learned that the Path to Health (02587) rose by more than 5%. As of press release, it had risen 4.07% to HK$0.64, with a turnover of HK$2.234 million.

According to news, Health Path has a comprehensive strategic layout of AI in recent years, focusing on medical scenarios to create AI digital employees. It has achieved remarkable results in reducing costs and increasing efficiency, and commercialized revenue generation in 2025. In the first half of this year, Health Path achieved revenue of 775 million yuan, an increase of 49.72% over the previous year; the company's equity shareholders should account for profit of 9.161 million yuan, an increase of 29.65% over the previous year. During this period, the company purchased a total of 2,412 million shares on the Stock Exchange at a total cost of about HK$117.107 million. The purpose of the buyback is to reflect the company's confidence in its business prospects and increase shareholder value.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.